ADACEL-POLIO

This brand name is authorized in Brazil, Canada, Hong Kong, New Zealand, Poland, Romania, Singapore

Active ingredients

The drug ADACEL-POLIO contains a combination of these active pharmaceutical ingredients (APIs):

1 Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
2 Diphtheria toxoid
UNII IRH51QN26H - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Diphtheria toxoid
3 Pertussis toxoid
UNII 63GD90PP8X - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
Read about Pertussis, purified antigen
4 Pertussis filamentous hemagglutinin
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Pertussis filamentous hemagglutinin
5 Pertactin
UNII 63GD90PP8X - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
Read about Pertussis, purified antigen
6 Pertussis fimbriae types 2 and 3
UNII 1O0600285A - BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN
Read about Pertussis, purified antigen
7 Polio virus type 2 (MEF 1)
UNII 23JE9KDF4R - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 2
8 Polio virus type 1 (Mahoney)
UNII 0LVY784C09 - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 1
9 Polio virus type 3 (Saukett)
UNII 459ROM8M9M - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 3

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07CA02 Diphtheria-pertussis-poliomyelitis-tetanus J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 576720040062417
Country: CA Health Products and Food Branch Identifier(s): 02352044
Country: HK Department of Health Drug Office Identifier(s): 56579
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12417
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100424777
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67254001, W67254002, W67254003, W67254004, W67254005, W67254006, W67254007
Country: SG Health Sciences Authority Identifier(s): 15479P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.